Type 1 diabetes concept suggested by insulin syringe] adrian825 Vertex Pharmaceuticals (NASDAQ:VRTX [ has posted new data from a Phase 1/2/3 study for zimislecel (VX-880), its experimental therapy for ...

Eli Lilly said on Saturday its experimental pill orforglipron helped diabetics lose weight and lower their blood sugar, and the company aims to announc ...

He shares his key takeaways from his experiences and why, ultimately, Tesla (TSLA) may have a leg up on the rival. To watch more expert insights and analysis on the latest market action, check out ...

Movers: GMS Inc. jumps after report of competing suitors ...

Northland analyst Bobby Brooks raised the firm’s price target on Groupon (GRPN) to $39 from $35 and keeps an Outperform rating on the shares after the company announced what the firm calls “an ...

In a compelling demonstration of analytical precision, InvestingPro’s Fair Value model identified a significant investment opportunity in Lucas GC Limited (NASDAQ:LGCL) that resulted in a 74% return ...

Despite the president’s domestic manufacturing push—and the Trump Organization’s launch of an ostensibly U.S.-made phone—the challenges remain massive. Continue Reading 查看留言 ...

Tesla (NASDAQ:TSLA) announced plans to invest approximately $8 billion in United States infrastructure and manufacturing during the current fiscal year, according to a post on X on late Friday. The ...

Marathon Petroleum continued assessing damage on Friday to the shut residual hydrotreating unit (RHU) at its 631,000-barrel-per-day (bpd) Galveston Bay Refinery in Texas City, Texas, from a June 14 ...

The Federal Aviation Administration said on Friday that the Jacksonville Air Route Traffic Control Center in Florida is experiencing a telecommunications issue that has resulted in a loss of radar, ...

Novo Nordisk A/S Subcutaneous amycretin phase 1b/2a data on the safety, tolerability and weight loss potential in people with overweight or obesity was published in The Lancet and presented at the ...

U.S. highway safety regulators are reviewing answers Tesla (NASDAQ:TSLA) gave in response to the agency’s questions about the safety of ...